Notably, few common loci with different methylation statuses between control and ADHD patients such as VIPR2 encoding the receptor for vasoactive intestinal peptide (VIP) expressed in the CNS and regional methylation patterns of neurotransmitters-associated pathways have been identified [7–9]. This evidence concerns the gene VIP and attention deficit-hyperactivity disorder.